Auph short interest
May 11, 2023 · The largest shareholder of Aurinia Pharmaceuticals ( NASDAQ: AUPH) said it plans to withholder support for seven board members at the company's upcoming annual meeting. Iljin SNT, which has a 6.1% ... AUPH - Short squeeze stock short interest data and short selling information for shares of Aurinia Pharmaceuticals Ord. Short interest stock data available for NASDAQ, NYSE, …AUPH has a market cap of $1.3bn and a cash balance of $389mn. Research and development expenses were USD 9.9 million for 4Q. Selling, general and administrative expenses, inclusive of share-based ...
Did you know?
Institutional Owners: 318 total, 304 long only, 0 short only, 14 long/short - change of 1.92% MRQ Average Portfolio Allocation: 0.0605 % - change of -12.95% MRQM&A season started earlier this week with TRIL / Pfizer, AUPH is one of the best candidate for the big pharmas. A weird Press Release appeared yesterday morning on different websites, likely fake or at least released to early, about a 35+ acquisition by a big pharma, it was later asked to be removed from Benzinga (but not denied) The short interestShort interest is the volume of Aurinia Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of October 31st, traders …View the basic AUPH option chain and compare options of Aurinia Pharmaceuticals Inc. on Yahoo Finance. ... Open Interest Implied Volatility; AUPH231215P00005000: 2023-11-15 12:00PM EST: 5.00: 0.04 ...Web
Jul 18, 2023 · Learn more about AUPH stock here. Skip to content. Explore Alpha Picks; ... Interest income rose to $3.8 million due to higher yields from increased interest rates. ... cash equivalents, and short ... It seems like the purpose of the document is to formalize the recent changes to the commercial partnership (originally announced here) as well as some of the items from the cooperation agreement released in February; particularly when it comes to the availability of stock warrants that Healios can execute once they achieve approvals for ARDS ... Aurinia Pharmaceuticals Ord. $ 7.29. AUPH (NASDAQ) -0.01. Short Squeeze Ranking™. view. Daily Short Sale Volume. view. Short Interest (Shares Short)On today's stock market, AUPH stock toppled 9.4% to 10.49. The hirings likely cooled investors' expectations that Aurinia could be looking for a buyout. In late 2021, reports suggested Bristol ...Web
Jun 29, 2023 · Aurinia Pharmaceuticals (AUPH) has begun to examine strategic alternatives that could include a potential sale or merger. ... Also, with 11%+ short interest, there should be some "motivated ... Dec 1, 2023 · The company has $337.90 million in cash and $93.21 million in debt, giving a net cash position of $244.69 million or $1.70 per share. Cash & Cash Equivalents. Learn more about AUPH stock here. Skip to content. Explore Alpha Picks; ... Interest income rose to $3.8 million due to higher yields from increased interest rates. ... cash equivalents, and short ... ….
Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. Auph short interest. Possible cause: Not clear auph short interest.
Track Aurinia Pharmaceuticals Inc (AUPH) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors Institutional Owners: 318 total, 304 long only, 0 short only, 14 long/short - change of 1.92% MRQ Average Portfolio Allocation: 0.0605 % - change of -12.95% MRQ
Introduction. This short interest tracker provides a variety of short interest related data, sourced from a variety of partners. The data is organized by frequency of updates, with intraday data at the top (short shares availability, short borrow fee rate), daily data (short volume, fails-to-deliver) in the middle, and the slowest updated data (short interest) at …The average of price targets set by Wall Street analysts indicates a potential upside of 46.1% in Aurinia (AUPH). While the effectiveness of this highly sought-after metric is questionable, the ...AUPH ($8.23) is undervalued by 7.05% relative to our estimate of its Fair Value price of $8.85 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
jepi vs divo 1K subscribers in the AUPH community. A place to discuss Aurinia Pharmaceuticals, Inc. oef etflevi price May 22, 2023 · @PITX3 not really great short squeeze potential, more like short caress. 11% of float takes 5 - 6 days to cover. From mid-April to mid-May the short position decreased by 2M down to 15.5M, 11% of ... Canadian biotech Aurinia Pharmaceuticals (AUPH) lost ~22% pre-market Thursday even after announcing better-than-expected financials for Q3 2022 as the company lowered its full-year... benicaros Aurinia Pharmaceuticals (AUPH) traded ~5% higher pre-market Thursday after the co. raised its outlook and posted better-than-expected Q2 2023 financials. Read more here. kellogg co stockhuntington bancshares incdoes usaa do motorcycle insurance Still, when we talk about a small-cap biotech that is clearly drawing the interest of some big pharma guys, we can say that AUPH's current valuation is very low, without but surely with buyout ... cheapest price of gold Amneal Pharmaceuticals saw a increase in short interest in November. As of November 15th, there was short interest totaling 3,620,000 shares, an increase of 13.5% from the previous total of 3,190,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are …WebThe 5-day price performance for the stock is 13.73%, and 26.09% over 30 days. With these gigs, the year-to-date price performance is 114.82%. Short interest in Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) saw shorts transact 17.28 million shares and set a 9.89 days time to cover. options actionmikimoto japanmarathon oil company stock Despite upbeat remarks from its chief executive ahead of the earnings, Aurinia’s (NASDAQ:AUPH) 2022 sales guidance fell short of expectations as net revenue for the year dropped ~9% YoY to $45 ...